Skip to main content
Equibles

BVF INC/IL

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1056807 San Francisco, CA
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$104,719,937
+$23,002,732 QoQ
Shares Held
5,750,683
0.0% QoQ
Ownership
8.94%
of shares outstanding
% of Portfolio
2.92%
of 13F equity value
Holder Rank
#3
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BVF INC/IL holds $3,440,293,274 across 41 Biotechnology names. CGEM ranks #10 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,965,160 $555,315,164
2 KYMR
Kymera Therapeutics, Inc.
 3,872,052 $444,008,202
3 MLTX
MoonLake Immunotherapeutics
 16,001,284 $311,544,999
4 GHRS
GH Research PLC
 8,650,158 $232,516,247
5 GPCR
Structure Therapeutics Inc.
 3,366,823 $180,697,390
6 NKTR
Nektar Therapeutics
 2,391,075 $166,920,945
7 MIRM
Mirum Pharmaceuticals, Inc.
 1,056,027 $123,629,080
8 XNCR
Xencor Inc
 7,133,720 $114,852,892

All Filings in CGEM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $104,719,937 5,750,683
2026-03-31 $81,717,205 5,750,683
2025-12-31 $59,519,569 5,750,683
2025-09-30 $34,101,550 5,750,683
2025-06-30 $43,302,642 5,750,683
2025-03-31 $43,532,670 5,750,683
2024-12-31 $70,043,318 5,750,683
2024-09-30 $96,266,433 5,750,683
2024-06-30 $100,291,911 5,750,683
2024-03-31 $54,471,785 3,196,701
2023-12-31 $32,574,383 3,196,701
2023-09-30 $28,930,144 3,196,701
2023-06-30 $34,396,502 3,196,701
2023-03-31 $32,702,251 3,196,701
2022-12-31 $79,220,572 7,509,059
2022-09-30 $96,266,136 7,509,059
2022-06-30 $96,266,136 7,509,059
2022-03-31 $56,218,235 5,369,459
2021-12-31 $82,850,752 5,369,459
2021-09-30 $16,591,342 735,106
2021-06-30 $18,928,979 735,106
2021-03-31 $43,726,664 1,049,356